Addex TherapeuticsADXN
About: Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
Employees: 23
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
50% more funds holding
Funds holding: 2 [Q2] → 3 (+1) [Q3]
0% less ownership
Funds ownership: 0% [Q2] → 0% (-0%) [Q3]
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
58% less capital invested
Capital invested by funds: $32.1K [Q2] → $13.6K (-$18.5K) [Q3]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Raghuram Selvaraju 37% 1-year accuracy 117 / 313 met price target | 293%upside $30 | Buy Reiterated | 2 Oct 2024 |